Verge Genomics

Verge Genomics

生物技术研究

South San Francisco,California 15,295 位关注者

Better drugs, faster. For patients who can’t wait.

关于我们

Verge Genomics is a clinical-stage biotechnology company transforming drug discovery and development using artificial intelligence (AI) and human data. Verge is focused on developing therapeutics for complex diseases with high unmet need, using human genomics from patient disease tissues and machine learning. Verge has created a proprietary all-in-human CONVERGE? platform, featuring one of the field’s largest and most comprehensive databases of multi-omic patient data. The company is led by experienced computational biologists and drug developers who are successfully advancing clinical and preclinical therapeutic programs in various diseases, including ALS and Parkinson’s disease. Verge actively seeks a diverse applicant pool in order to build the strongest possible workforce. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.

网站
https://www.vergegenomics.com
所属行业
生物技术研究
规模
51-200 人
总部
South San Francisco,California
类型
私人持股
创立
2015
领域
Bioinformatics、Genomics、Drug Discovery、Neuroscience、ALS和FTD

地点

  • 主要

    131 Oyster Point Blvd

    US,California,South San Francisco,94080

    获取路线

Verge Genomics员工

动态

相似主页

查看职位

融资